Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 239

The DOI matches its Crossref record.

The Effect of Topical Bevacizumab on Corneal Neovascularization

Open access
Kim, Sang Woo, Ha, Byung Jin, Kim, Eung Kweon, Tchah, Hungwon, Kim, Tae-im·2008·Ophthalmology

Abstract

PURPOSE To examine the effect of topical bevacizumab on corneal neovascularization (NV) over a period of 3 months. DESIGN Prospective, nonrandomized, masked observational case series. PARTICIPANTS Ten eyes of 7 patients with corneal NV. METHODS Patients received topical bevacizumab (1.25%) twice daily. Ophthalmic evaluations included visual acuity, slit-lamp examination, and tonometry. MAIN OUTCOME MEASURES Corneal NV and changes in ophthalmic evaluations. RESULTS Decreased corneal NV was noted in 7 of 10 eyes, usually within 1 month of treatment. Epitheliopathy (epithelial defect, epithelial erosion) was observed in 6 of 10 eyes, 1 resulting in corneal thinning. Adverse effects generally appeared during the second month of treatment. CONCLUSIONS Topical application of bevacizumab was effective in reducing corneal NV within the first month. However, by the second month there was an increased risk of adverse effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2008.02.013

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 239

Metadata

Authors
Kim, S. W., Ha, B. J., Kim, E. K., Tchah, H., & Kim, T.-I.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2008-06
Volume
115
Issue
6
Pages
e33-e38
ISSN
0161-6420 (ISSN-L)
OpenAlex
W2099087156
Cited by
239
References
0
FWCI
16.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effect of Topical Bevacizumab on Corneal Neovascularization. https://app.cochat.ai/papers/10.1016/j.ophtha.2008.02.013
The paper
Kim, S. W., Ha, B. J., Kim, E. K., Tchah, H., & Kim, T.-I. (2008). The Effect of Topical Bevacizumab on Corneal Neovascularization. Ophthalmology. https://doi.org/10.1016/j.ophtha.2008.02.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.